Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy.

Elżbieta Cecerska-HeryćRafał HeryćGrażyna DutkiewiczAnna MichalczykBartłomiej GrygorcewiczNatalia SerwinSylwia Napiontek-BalińskaBarbara Dołęgowska

Published in: BMC nephrology (2022)

The type of renal replacement therapy used in CKD patients, age of patients, duration of dialysis, CKD causes, and stage of progression significantly affect the activity of XOR and its isoforms.

Keyphrases

end stage renal disease
chronic kidney disease
oxidative stress
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
acute kidney injury
signaling pathway
patient reported outcomes